sur LNA SANTE (EPA:LNA)
LNA Santé Reports Steady Growth in H1 2024 Results
LNA Santé, a global healthcare player, showcased resilience amidst challenging market conditions in the first half of 2024. The company reported operating sales of €386.3 million, reflecting an 8.2% increase compared to the previous year, with a 5.7% organic growth adjustment.
Operating EBITDA was €72.0 million, marking a slight rise of 1.1%. Net operating profit stood at €15.0 million, a 5.1% increase, demonstrating strong resilience in a complex pricing environment due to the SMR pricing reform. Though the EBITDA margin slightly declined to 18.6%, LNA Santé maintained a robust financial standing.
The company’s net debt was reported at €121.2 million, showing an improvement in leverage ratios. Liquid assets of €170 million are earmarked to support development initiatives. The positive financial indicators allowed LNA Santé to reaffirm its 2024 outlook, targeting an adjusted organic growth of 5.0% and stable results.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de LNA SANTE